Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2019 2
2020 4
2021 7
2022 3
2023 2
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Lee I, Kuo HC, Aban IB, Cutter GR, McPherson T, Kaminski HJ, Sussman J, Ströbel P, Oger J, Cea G, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJG, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Minisman G, Sonett JR, Wolfe GI; MGTX study group. Lee I, et al. Neurology. 2020 Aug 11;95(6):e755-e766. doi: 10.1212/WNL.0000000000010031. Epub 2020 Jul 1. Neurology. 2020. PMID: 32611638 Free PMC article. Clinical Trial.
Hemorrhagic rash on the legs.
Traidl S, Angela Y, Kapp A, Schefzyk M. Traidl S, et al. Among authors: angela y. JAAD Case Rep. 2021 Apr 24;12:67-69. doi: 10.1016/j.jdcr.2021.04.015. eCollection 2021 Jun. JAAD Case Rep. 2021. PMID: 34041335 Free PMC article. No abstract available.
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma.
DeTemple VK, Kaatz M, Stockfleth E, Scheel C, Angela Y, Gutzmer R, Leiter U, Meier F, Schadendorf D, Livingstone E, Gebhardt C, von Wasielewski I, Weichenthal M, Mohr P, Hassel J, Pföhler C, Simon JC, Jochims F, Terheyden P, Ulrich J, Haferkamp S, Drexler K, Schilling B, Glutsch V, Heinzerling L, Berking C, Ugurel S, Tomsitz D. DeTemple VK, et al. Among authors: angela y. Eur J Cancer. 2025 Jul 25;225:115590. doi: 10.1016/j.ejca.2025.115590. Epub 2025 Jun 24. Eur J Cancer. 2025. PMID: 40580809 Free article.
Langerhans cell histiocytosis mimicking prurigo nodularis.
Traidl S, Angela Y, Wedi B, Kapp A, Werfel T, Schacht V. Traidl S, et al. Among authors: angela y. J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e259-e261. doi: 10.1111/jdv.16991. Epub 2020 Nov 3. J Eur Acad Dermatol Venereol. 2021. PMID: 33040393 No abstract available.
First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG.
Reinhard S, Utikal JS, Zaremba A, Lodde G, von Wasielewski I, Klespe KC, Meier F, Haferkamp S, Kähler KC, Herbst R, Gebhardt C, Sindrilaru A, Dippel E, Angela Y, Mohr P, Pfoehler C, Forschner A, Kaatz M, Schell B, Gesierich A, Loquai C, Hassel JC, Ulrich J, Meiss F, Schley G, Heinzerling LM, Sachse M, Welzel J, Weishaupt C, Sunderkötter C, Michl C, Lindhof HH, Kreuter A, Heppt MV, Wenk S, Mauch C, Berking C, Nedwed AS, Gutzmer R, Leiter U, Schadendorf D, Ugurel S, Weichenthal M, Haist M, Fleischer MI, Lang B, Grabbe S, Stege H. Reinhard S, et al. Among authors: angela y. Eur J Cancer. 2025 May 2;220:115356. doi: 10.1016/j.ejca.2025.115356. Epub 2025 Mar 15. Eur J Cancer. 2025. PMID: 40121837 Free article.
24 results